AU2012900065A0 - Cancer Therapy: Inhibiting or slowing-down the recurrence of glioblastoma by injecting a brain tissue-compatible scaffold containing tumor growth inhibitors at the site of primary tumor - Google Patents

Cancer Therapy: Inhibiting or slowing-down the recurrence of glioblastoma by injecting a brain tissue-compatible scaffold containing tumor growth inhibitors at the site of primary tumor

Info

Publication number
AU2012900065A0
AU2012900065A0 AU2012900065A AU2012900065A AU2012900065A0 AU 2012900065 A0 AU2012900065 A0 AU 2012900065A0 AU 2012900065 A AU2012900065 A AU 2012900065A AU 2012900065 A AU2012900065 A AU 2012900065A AU 2012900065 A0 AU2012900065 A0 AU 2012900065A0
Authority
AU
Australia
Prior art keywords
glioblastoma
recurrence
slowing
inhibiting
injecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012900065A
Inventor
Mohammad-Taghi Daneshvar
Seyed Javad Mowla
Hooshang Saberi
Afsaneh Malekzadeh Shafaroudi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2012900065A0 publication Critical patent/AU2012900065A0/en
Abandoned legal-status Critical Current

Links

AU2012900065A 2012-01-03 Cancer Therapy: Inhibiting or slowing-down the recurrence of glioblastoma by injecting a brain tissue-compatible scaffold containing tumor growth inhibitors at the site of primary tumor Abandoned AU2012900065A0 (en)

Publications (1)

Publication Number Publication Date
AU2012900065A0 true AU2012900065A0 (en) 2012-02-02

Family

ID=

Similar Documents

Publication Publication Date Title
IL274647A (en) Methods for treating non- small cell lung cancer using tor kinase inhibitor combination therapy
HRP20190046T1 (en) Combination therapy for the treatment of cancer
IL258612B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
HRP20150692T8 (en) Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
HK1207861A1 (en) Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1
PL2922828T3 (en) 4,6-diamino-pyrimidine derivatives as bmi-1 inhibitors for treating cancer
HK1206937A1 (en) Methods of administering pirfenidone therapy
EP2671586A4 (en) Drug therapy for preventing or treating glaucoma
EP2788378A4 (en) Combination therapy for treatment of cancer
EP2830633A4 (en) Combination therapy for the treatment of cancer
EP2776042A4 (en) Combination drug therapy for the treatment of solid tumors
WO2011123427A9 (en) Treatment of cancer by inhibiting activity or expression of late sv-40 factor
ZA201300762B (en) Novel combination therapy for the treatment of cancer
WO2014062878A3 (en) Treatment of prostate cancer with tor kinase inhibitors
IL275636A (en) Therapeutic combination for the treatment of cancer
HK1223832A1 (en) Kinase inhibitors for the treatment of cancer
HK1206253A1 (en) Methods of treating cancer using aurora kinase inhibitors
MX366911B (en) Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase i inhibitor.
AU2012900065A0 (en) Cancer Therapy: Inhibiting or slowing-down the recurrence of glioblastoma by injecting a brain tissue-compatible scaffold containing tumor growth inhibitors at the site of primary tumor
EP2707008A4 (en) Use of arsenic for cancer therapy protection
EP2807191B8 (en) Methods of treating pain by inhibition of vgf activity
WO2012106461A9 (en) Combination therapy for treatment of cancer
HK1202239A1 (en) Combination drug therapy for the treatment of solid tumors
IL233495A0 (en) Combination therapy for the treatment of cancer
AU2012901199A0 (en) Kinase inhibitors for the Treatment of Cancer